Literature DB >> 18431365

Relationships between leptin and C-reactive protein with cardiovascular disease in the adult general population.

Abel Romero-Corral1, Justo Sierra-Johnson, Francisco Lopez-Jimenez, Randal J Thomas, Prachi Singh, Michal Hoffmann, Aynur Okcay, Josef Korinek, Robert Wolk, Virend K Somers.   

Abstract

BACKGROUND: Leptin could be a key regulator of C-reactive protein (CRP) levels, which serve as a marker of systemic inflammation. Both leptin and CRP are predictors of cardiovascular disease (CVD). However, the interactions between leptin and CRP, and their association with CVD, remain unclear. We therefore studied them in a large, multiethnic population.
METHODS: We analyzed leptin and CRP levels, anthropometric variables and cardiovascular risk factor data from 6,251 participants from the Third National Health and Nutrition Examination Survey (NHANES III). Logistic regression was used to estimate the association between leptin, CRP and CVD (defined as history of myocardial infarction or stroke). Receiver operating characteristic curves were created to study the additional value of leptin and CRP for the association with CVD.
RESULTS: The mean age was 44.4 +/- 0.21 years (52.5% women). After adjustment for age, race, dyslipidemia, hypertension, diabetes, smoking, obesity and CRP, high levels of leptin were significantly associated with CVD in men (odds ratio 2.47, 95% CI 1.19-5.19) and in women (odds ratio 3.30, 95% CI 1.47-7.99). After adjustment for leptin, CRP was not associated with CVD. There was a significant correlation between levels of leptin and CRP (Spearman correlation rho = 0.22 in men and rho = 0.32 in women, both P < 0.0001). The area under the curve, representing the association between cardiovascular risk factors and CVD, increased after the addition of high levels of both leptin and CRP together.
CONCLUSION: High leptin levels are independently associated with CVD even after adjustment for CRP; elevated CRP levels are not associated with CVD after adjustment for leptin. However, increased concentrations of both leptin and CRP confer the highest risk for CVD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18431365     DOI: 10.1038/ncpcardio1218

Source DB:  PubMed          Journal:  Nat Clin Pract Cardiovasc Med        ISSN: 1743-4297


  20 in total

1.  Leptin, abdominal obesity, and onset of depression in older men and women.

Authors:  Yuri Milaneschi; Eleanor M Simonsick; Nicole Vogelzangs; Elsa S Strotmeyer; Kristine Yaffe; Tamara B Harris; Magdalena I Tolea; Luigi Ferrucci; Brenda W J H Penninx
Journal:  J Clin Psychiatry       Date:  2012-05-29       Impact factor: 4.384

2.  C-reactive protein modifies the association of plasma leptin with coronary calcium in asymptomatic overweight individuals.

Authors:  Seth S Martin; Atif N Qasim; Dan J Rader; Muredach P Reilly
Journal:  Obesity (Silver Spring)       Date:  2011-07-07       Impact factor: 5.002

Review 3.  Obesity: the 'huge' problem in cardiovascular diseases.

Authors:  M Javed Ashraf; Paramdeep Baweja
Journal:  Mo Med       Date:  2013 Nov-Dec

4.  Vitamin D supplementation during exercise training does not alter inflammatory biomarkers in overweight and obese subjects.

Authors:  Andres E Carrillo; Michael G Flynn; Catherine Pinkston; Melissa M Markofski; Yan Jiang; Shawn S Donkin; Dorothy Teegarden
Journal:  Eur J Appl Physiol       Date:  2011-12-20       Impact factor: 3.078

5.  Leptin upregulates the expression of plasminogen activator inhibitor-1 in human vascular endothelial cells.

Authors:  Prachi Singh; Timothy E Peterson; Kara R Barber; Fatima Sert Kuniyoshi; Andrus Jensen; Michal Hoffmann; Abu S M Shamsuzzaman; Virend K Somers
Journal:  Biochem Biophys Res Commun       Date:  2010-01-05       Impact factor: 3.575

6.  Carbon monoxide poisoning, or carbon monoxide protection?

Authors:  Robert L Owens; Susie Yim-Yeh; Atul Malhotra
Journal:  Chest       Date:  2008-11       Impact factor: 9.410

7.  Sex and ethnic differences in 47 candidate proteomic markers of cardiovascular disease: the Mayo Clinic proteomic markers of arteriosclerosis study.

Authors:  Charles X Kim; Kent R Bailey; George G Klee; Allison A Ellington; Guanghui Liu; Thomas H Mosley; Hamid Rehman; Iftikhar J Kullo
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

8.  Alterations in Lipids and Adipocyte Hormones in Female-to-Male Transsexuals.

Authors:  Prakash Chandra; Sukhdeep S Basra; Tai C Chen; Vin Tangpricha
Journal:  Int J Endocrinol       Date:  2010-07-18       Impact factor: 3.257

9.  Effect of increased leptin and C-reactive protein levels on mortality: results from the National Health and Nutrition Examination Survey.

Authors:  Stephen M Amrock; Michael Weitzman
Journal:  Atherosclerosis       Date:  2014-06-23       Impact factor: 5.162

10.  Serum Leptin Levels and the Risk of Stroke: The Framingham Study.

Authors:  Hamidreza Saber; Jayandra J Himali; Ashkan Shoamanesh; Alexa Beiser; Aleksandra Pikula; Tamara B Harris; Ronenn Roubenoff; Jose Rafael Romero; Carlos S Kase; Ramachandran S Vasan; Sudha Seshadri
Journal:  Stroke       Date:  2015-09-03       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.